- Home
- BWIN vs ACHC Comparison
BWIN vs ACHC Comparison
Compare BWIN & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWIN
- ACHC
- Stock Information
- Founded
- BWIN 2011
- ACHC 2005
- Country
- BWIN United States
- ACHC United States
- Employees
- BWIN N/A
- ACHC N/A
- Industry
- BWIN Specialty Insurers
- ACHC Medical Specialities
- Sector
- BWIN Finance
- ACHC Health Care
- Exchange
- BWIN Nasdaq
- ACHC Nasdaq
- Market Cap
- BWIN 1.7B
- ACHC 1.7B
- IPO Year
- BWIN 2019
- ACHC N/A
- Fundamental
- Price
- BWIN $26.75
- ACHC $19.41
- Analyst Decision
- BWIN Hold
- ACHC Strong Buy
- Analyst Count
- BWIN 7
- ACHC 12
- Target Price
- BWIN $38.29
- ACHC $34.83
- AVG Volume (30 Days)
- BWIN 1.0M
- ACHC 2.1M
- Earning Date
- BWIN 11-04-2025
- ACHC 11-05-2025
- Dividend Yield
- BWIN N/A
- ACHC N/A
- EPS Growth
- BWIN N/A
- ACHC N/A
- EPS
- BWIN N/A
- ACHC 1.18
- Revenue
- BWIN $1,487,497,000.00
- ACHC $3,265,548,000.00
- Revenue This Year
- BWIN $10.87
- ACHC $7.20
- Revenue Next Year
- BWIN $12.60
- ACHC $6.65
- P/E Ratio
- BWIN N/A
- ACHC $16.52
- Revenue Growth
- BWIN 10.69
- ACHC 4.58
- 52 Week Low
- BWIN $21.26
- ACHC $17.13
- 52 Week High
- BWIN $50.46
- ACHC $47.08
- Technical
- Relative Strength Index (RSI)
- BWIN 56.65
- ACHC 24.63
- Support Level
- BWIN $21.26
- ACHC $18.32
- Resistance Level
- BWIN $24.58
- ACHC $23.77
- Average True Range (ATR)
- BWIN 1.10
- ACHC 0.97
- MACD
- BWIN 0.60
- ACHC -0.42
- Stochastic Oscillator
- BWIN 98.39
- ACHC 19.01
About BWIN The Baldwin Insurance Group Inc. Class A Common Stock
The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.